LM Advisors LLC Has $915,000 Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

LM Advisors LLC boosted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,919 shares of the financial services provider’s stock after purchasing an additional 245 shares during the quarter. LM Advisors LLC’s holdings in iShares Biotechnology ETF were worth $915,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth $55,010,000. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Aprio Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $18,476,000. Generali Investments CEE investicni spolecnost a.s. bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $11,370,000. Finally, Independent Advisor Alliance acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $6,769,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $131.14 on Thursday. The firm has a 50 day simple moving average of $136.23 and a two-hundred day simple moving average of $139.11. The company has a market cap of $6.20 billion, a P/E ratio of 27.83 and a beta of 0.84. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were given a dividend of $0.1212 per share. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.